SNTI Latest Press Releases

-- July 15, 2026 --

Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable Genetic Medicines Powered by its Regulator Dial Technology Platform Globe Newswire 7:30 AM

-- June 29, 2026 --

The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change Business Wire 4:10 PM

-- May 14, 2026 --

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase Globe Newswire 8:45 AM

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program Globe Newswire 8:40 AM

-- April 13, 2026 --

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026 Globe Newswire 9:00 AM

-- April 1, 2026 --

Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies Globe Newswire 8:45 AM

-- March 27, 2026 --

Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software